MLNCX
Price
$26.17
Change
-$0.17 (-0.65%)
Updated
Jun 2 closing price
Net Assets
423.72M
RNPFX
Price
$75.82
Change
+$0.09 (+0.12%)
Updated
Jun 2 closing price
Net Assets
164.3B
Interact to see
Advertisement

MLNCX vs RNPFX

Header iconMLNCX vs RNPFX Comparison
Open Charts MLNCX vs RNPFXBanner chart's image
MLNCX vs RNPFX Comparison Chart in %
View a ticker or compare two or three
VS
MLNCX vs. RNPFX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLNCX is a Buy and RNPFX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNPFX has more cash in the bank: 164B vs. MLNCX (424M). RNPFX pays higher dividends than MLNCX: RNPFX (1.18) vs MLNCX (0.00). MLNCX was incepted earlier than RNPFX: MLNCX (10 years) vs RNPFX (24 years). MLNCX (2.08) is less costly to investors than RNPFX (0.45). MLNCX is a more actively managed with annual turnover of: 51.00 vs. RNPFX (23.00). RNPFX has a lower initial minimum investment than MLNCX: RNPFX (250) vs MLNCX (1000). RNPFX annual gain was more profitable for investors over the last year : 14.29 vs. MLNCX (11.09). MLNCX return over 5 years is better than : 43.31 vs. RNPFX (20.94).
MLNCXRNPFXMLNCX / RNPFX
Total Expense Ratio2.080.45462%
Annual Report Gross Expense Ratio2.080.45462%
Fund Existence10 years24 years-
Gain YTD4.4007.35860%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets424M164B0%
Annual Yield % from dividends0.001.18-
Returns for 1 year11.0914.2978%
Returns for 3 years73.1845.67160%
Returns for 5 years43.3120.94207%
Returns for 10 years162.66118.48137%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GAIN16.010.11
+0.69%
Gladstone Investment Corp
EXFY1.17N/A
+0.43%
Expensify
BEKE17.230.05
+0.29%
KE Holdings
MBIO0.76-0.01
-0.86%
Mustang Bio Inc
HAE66.37-0.85
-1.26%
Haemonetics Corp